All Stories

  1. Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence

    Article • Alimentary Pharmacology & Therapeutics, May 2017, Wiley

    Ralf Mohrbacher, Andrey Dorofeyev

  2. Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis

    Article • Gastroenterology, May 2014, Elsevier

    Ralf Mohrbacher, Fernando Fernández-Bañares

  3. Improvement in Oral Chronic Graft-versus-Host Disease with the Administration of Effervescent Tablets of Topical Budesonide—An Open, Randomized, Multicenter Study

    Article • Biology of Blood and Marrow Transplantation, January 2012, Elsevier

    Ralf Mohrbacher

  4. Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

    Article • Gastroenterology, February 2011, Elsevier

    Ralf Mohrbacher

  5. Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis

    Article • Inflammatory Bowel Diseases, November 2010, Wolters Kluwer Health

    Ralf Mohrbacher